Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic

Lancet

Volumn 354, Issue 9190, 1999, Pages 1615-

  Peruzzi, Licia ^a   Gianoglio, Bruno ^a   Porcellini, Maria Gabriella ^a   Coppo, Rosanna ^a  

^a Regina Margherita Children's H   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; NIMESULIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; FETOTOXICITY; HUMAN; KIDNEY FAILURE; NEWBORN; PRIORITY JOURNAL; TOCOLYSIS;

EID: 0345493647     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03105-0     Document Type: Article

References (5)

1. Sawdy R., Slater D., Fisk N., Edmonds D.K., Bennet P. Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery. Lancet. 350:1997;265-266.
2. Ostensen M. Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J Rheumatol. 27(suppl 107):1998;128-213.
3. Slater D.M., Berger L.C., Newton R., Moore G.E., Bennet P.R. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol. 172:1995;77-82.
4. Dinchuk J.E., Car B.D., Fochet R.J.et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 378:1995;406-409.
5. Zhang M.Z., Wang J.L., Cheng H.F., Harris R.C., McKanna J.A. Cyclooxygenase-2 in rat nephron development. Am J Physiol. 273:1997;F994-1002.